Prediction of improvement in quality of life (QoL-AGHDA) in adults with growth hormone deficiency by normative reference limits: Data of the German KIMS cohort

Growth Hormone and IGF Research

Volumn 21, Issue 5, 2011, Pages 272-278

  Moock, Joern ^a   Friedrich, Nele ^a   Völzke, Henry ^a   Spielhagen, Christin ^a   Nauck, Matthias ^a   Koltowska Häggström, Maria ^b   Buchfelder, Michael ^c   Wallaschofski, Henri ^a   Kohlmann, Thomas ^a  

^a UNIVERSITY MEDICINE GREIFSWALD   (Germany)

^b PFIZER INC   (United States)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Growth hormone deficiency; IGF I; Normative reference values; Quality of life health related quality of life; Quantile regression

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; FEMALE; GERMANY; GROWTH HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MALE; NORMAL VALUE; PATIENT ASSESSMENT; PREDICTION; PRIORITY JOURNAL; QUALITY OF LIFE; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY; TOTAL QUALITY MANAGEMENT; TREATMENT RESPONSE;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; COHORT STUDIES; DATABASES AS TOPIC; FEMALE; GERMANY; GROWTH HORMONE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; QUALITY OF LIFE; QUESTIONNAIRES; REFERENCE STANDARDS; RETROSPECTIVE STUDIES; ROC CURVE; SEX FACTORS;

EID: 80052572912     PISSN: 10966374     EISSN: 15322238     Source Type: Journal    
DOI: 10.1016/j.ghir.2011.07.005     Document Type: Article

References (34)

1. Carroll P.V., Christ E.R., Bengtsson B.A., Carlsson L., Christiansen J.S., Clemmons D., Hintz R., Ho K., Laron Z., Sizonenko P., Sonksen P.H., Tanaka T., Thorne M. Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. Growth Hormone Research Society Scientific Committee. J. Clin. Endocrinol. Metab. 1998, 83:382-395.
2. Björk S., Jonsson B., Westphal O., Levin J.E. Quality of life of adults with growth hormone deficiency: a controlled study. Acta Paediatr. Suppl. 1989, 356:55-59.
3. McGauley G.A., Cuneo R., Salomon F., Sönksen P.H. Psychological well-being before and after growth hormone treatment in adults with growth hormone deficiency. Horm. Res. 1990, 33:52-54.
4. Wallymahmed M.E., Foy P., Shaw D., Hutcheon R., Edwards E.H.T., MacFarlane I.A. Quality of life, body composition and muscle strength in adult growth hormone deficiency: the influence of growth hormone replacement therapy up to 3years. Clin. Endocrinol. 1997, 47:439-446.
5. Wirén L., Bengtsson B.A., Johannsson G. Beneficial effects of long-term GH replacement therapy on quality of life in adults with GH deficiency. Clin. Endocrinol. 1998, 48:613-620.
6. Rosén T., Wirén L., Wilhelmsen L., Wiklund I., Bengtson B.A. Decreased psychological wellbeing in adult patients with growth hormone deficiency. Clin. Endocrinol. 1994, 40:111-116.
7. Webb S.M., Badia X. Quality of life in growth hormone deficiency and acromegaly. Endocrinol. Metab. Clin. N. Am. 2007, 36:221-232.
8. Gilchrist F.J., Murray R.D., Shalet S.M. The effect of long-term untreated growth hormone deficiency (GHD) and 9years of GH replacement on the quality of life (QoL) of GH-deficient adults. Clin. Endocrinol. 2002, 57:363-370.
9. Spielhagen C., Schwahn C., Möller K., Friedrich N., Kohlmann T., Moock J., Kołtowska-Häggström M., Nauck M., Buchfelder M., Wallaschofski H. The benefit of long-term growth hormone (GH) replacement therapy in hypopituitary adults with GH deficiency: results of the German KIMS database. Growth Horm. IGF Res. 2011, 21:1-10.
10. Svensson J., Finer N., Bouloux P., Bevan J., Jonsson B., Mattsson A.F., Lundberg M., Harris P.E., Koltowska-Häggström M., Monson J.P. KIMS International Board, Growth hormone (GH) replacement therapy in GH deficient adults: predictors of one-year metabolic and clinical response. Growth Horm. IGF Res. 2007, 17:67-76.
11. Ho K.K. GH Deficiency Consensus Workshop Participants, Consensus guidelines for the diagnosis and treatment of adults with GH deficiency II: a statement of the GH Research Society in association with the European Society for Paediatric Endocrinology, Lawson Wilkins Society, European Society of Endocrinology, Japan Endocrine Society, and Endocrine Society of Australia. Eur. J. Endocrinol. 2007, 157:695-700.
12. Ranke M.B., Lindberg A. KIGS International Board, Observed and predicted growth responses in prepubertal children with growth disorders: guidance of growth hormone treatment by empirical variables. J. Clin. Endocrinol. Metab. 2010, 95:1229-1237.
13. Gutiérrez L.P., Koltowska-Häggström M., Jönnson P.J., Mattson A.F., Svensson D., Westberg B., Luger A. Registries as a Tool in Evidence-Based Medicine: example of KIMS. Pharmacoepidemiol. Drug Saf. 2008, 17:90-102.
14. John U., Greiner B., Hensel E., Lüdemann J., Piek M., Sauer S., Adam C., Born G., Alte D., Greiser E., Haertel U., Hense H.W., Haerting J., Willich S., Kessler C. Study of Health in Pommerania (SHIP): a health examination survey in an East German region: objectives and design. SPM 2000, 46:146-194.
15. McKenna S.P., Doward L.C., Alonso J., Kohlmann T., Niero M., Prieto L., Wiren L. The QoL-AGHDA: an instrument for the assessment of quality of life in adults with growth hormone deficiency. Qual. Life Res. 1999, 8:373-383.
16. McKenna S.P., Doward L. Measuring quality of life in adults with growth hormone deficiency. Clin. Endocrinol. 1996, 45:507-508.
17. Moock J., Albrecht C., Friedrich N., Völzke H., Nauck M., Koltowska-Haggström M., Kohlmann T., Wallaschofski H. Health-related quality of life and IGF-1 in GH-deficient adult patients on GH replacement therapy: analysis of the German KIMS data and the Study of Health in Pomerania. Eur. J. Endocrinol. 2009, 160:17-24.
18. Gutiérrez L.P., Koltowska-Häggström M., Jönnson P.J., Mattson A.F., Svensson D., Westberg B., Luger A. Registries as a Tool in Evidence-Based Medicine: example of KIMS (Pfizer International Metabolic Database). Pharmacoepidemiol. Drug Saf. 2008, 17:90-102.
19. von Elm E., Altman D.G., Egger M., Pocock S.J., Gøtzsche P.C., Vandenbroucke J.P. STROBE Initiative, The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med. 2007, 4:e296.
20. Koenker R. Quantile Regression, Econometric Society Monograph Series 2005, Cambridge University Press, New York.
21. Wirén L., Whalley D., McKenna S.P., Wilhelmsen L. Application of a disease-specific, quality-of-life measure (QoL-AGHDA) in growth hormone-deficient adults and a random population sample in Sweden: validation of the measure by Rasch analysis. Clin. Endocrinol. 2000, 52:143-152.
22. Koltowska-Häggström M., Mattsson A.F., Monson J.P., Kind P., Badia X., Casanueva F.F., Busschbach J., Koppeschaar H.P., Johannsson G. Does long-term GH replacement therapy in hypopituitary adults with GH deficiency normalise quality of life. Eur. J. Endocrinol. 2006, 155:109-119.
23. Badia X., Lucas A., Sanmarti A., Roset M., Ulied A. One-year follow-up of quality of life in adults with untreated growth hormone deficiency. Clin. Endocrinol. 1998, 49:765-771.
24. Koltowska-Häggström M., Hennessy S., Mattsson A.F., Monson J.P., Kind P. Quality of life assessment of growth hormone deficiency in adults (QoL-AGHDA): comparison of normative reference data for the general population of England and Wales with results for adult hypopituitary patients with growth hormone deficiency. Horm. Res. 2005, 64:46-54.
25. Malik I.A., Foy P., Wallymahmed M., Wilding J.P.H., MacFarlane I.A. Assessment of quality of life in adults receiving long-term growth hormone replacement compared to control subjects. Clin. Endocrinol. 2003, 59:75-81.
26. Hürny C., Bernhard J., Gelber R.D., Coates A., Castiglione M., Isley M., Dreher D., Peterson H., Goldhirsch A., Senn H.J. for the International Breast Cancer Study Group, Quality of life measures for patients receiving adjuvant therapy for breast cancer: an international trial. Eur. J. Cancer 1992, 28:118-124.
27. Barkan A.L. The quality of life assessment of growth hormone deficiency in adults' questionnaire: can it be used to assess quality of life in hypopituitarism. J. Clin. Endocrinol. Metab. 2001, 86:1905-1907.
28. Inglehart R., Jacques-Rene R. Aspirations adapt to situations - but why are the Belgians so much happier than the French? A cross-cultural analysis of the subjective quality of life. Research on the Quality of Life 1986, 1-56. University of Michigan, Ann Arbor, Institute for Social Research, ch. 1. edn 1. F.M. Andrews (Ed.).
29. Koltowska-Häggström M., Kind P. Evaluating Outcomes in Adult Growth Hormone Deficiency (AGHD): The Status of Quality of Life (QoL) Measurement in Clinical Studies, ENDO Abstract Book, P2-320, p 383 2003, Chevy Chase, The Endocrine Society Press.
30. Radcliffe D.J., Pliskin J.S., Silvers J.B., Cuttler L. Growth hormone therapy and quality of life in adults and children. PharmacoEconomics 2004, 22:499-524.
31. Webb S.M. Measurements of quality of life in patients with growth hormone deficiency. J. Endocrinol. Invest. 2008, 31:52-55.
32. Molitch M.E., Clemmons D.R., Malozowski S., Merriam G.R., Vance M.L. Evaluation and treatment of adult growth hormone deficiency: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 2011, 96:1587-1609.
33. Garratt A.M., Schmidt L., Mackintosh A., Fitzpatrick R. Quality of life measurement: bibliographic study of patient assessed health outcome measures. BMJ 2002, 324:1417-1421.
34. Fayers P.M., Machin D. Introduction. Quality of life: Assessment, Analysis and Interpretation 2000, 1-36. John Wiley & Sons, Chichester, (ch. 1). edn 1. P.M. Fayers, D. Machin (Eds.).